Announced
Synopsis
GVS, a provider of advanced filtration solutions for critical applications, agreed to acquire Puerto Rico-based manufacturing operations of Haemonetics, a global medical technology company focused on delivering innovative hematology solutions. This transaction is expected to close in the second quarter of calendar 2020, subject to the satisfaction of customary closing conditions. Financial terms were not disclosed. "We are honored that Haemonetics, an industry leader and one of our long-term clients, has chosen GVS for this strategic partnership, which is testament to our technological and process capabilities. This collaboration will provide us with a new channel for R&D, stimulating the introduction of new products, ideas and solutions for the blood filtration market," Massimo Scagliarini, GVS CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.